Cannabis (Cannabis sativa L.) is cultivated globally for its applications in medicine, fiber, oil, and seed production. With growing interest in cannabidiol (CBD) for its therapeutic potential and increasing regulation of tetrahydrocannabinol (THC) du...
Cannabis (Cannabis sativa L.) is cultivated globally for its applications in medicine, fiber, oil, and seed production. With growing interest in cannabidiol (CBD) for its therapeutic potential and increasing regulation of tetrahydrocannabinol (THC) due to its psychoactive effects, the development of Cannabis cultivars with high CBD and low or null THC content has become a major breeding objective. Agrobacterium-mediated transformation is a well-established method for producing stably transformed plants, and recent advances in CRISPR/Cas9 gene-editing technology have further enabled precise genome modifications in a variety of plant species. In this study, I aimed to establish an efficient and reproducible in vitro regeneration and transformation system for Cannabis, in combination with CRISPR/Cas9 genome editing, to generate gene-edited lines with altered cannabinoid profiles.
Sterilization protocols were optimized using seeds of the Cannabis cultivar ‘Cheongsam’. Seeds treated with 1% hydrogen peroxide (H₂O₂) for 2 days in the dark, followed by husk and embryo membrane removal and a 0.2% sodium hypochlorite (NaClO) treatment for 15 minutes, showed a contamination rate reduced to 5%. Further contamination control was achieved by culturing on Murashige and Skoog (MS) medium containing 300 mg/L timentin, which effectively suppressed microbial growth without inhibiting seedling development. Cotyledon explants containing shoot apical meristem (SAM) regions and mature embryos were used for regeneration. Explants were co-cultivated with Agrobacterium tumefaciens strains LBA4404, GV3101, and AGL1 harboring CRISPR/Cas9 vectors pECO200 and pBAtC targeting the CsTHCAS gene, which encodes tetrahydrocannabinol acid synthase. Explants were cultured on MS medium supplemented with 0.4 mg/L thidiazuron (TDZ) and 0.2 mg/L 1-naphthaleneacetic acid (NAA), followed by transfer to rooting medium. After selection and molecular analysis, a total of six gene-edited Cannabis lines were obtained with insertions and deletions (In/Del) mutation rates of 0.6%, 0.2%, 0.3%, 0.3%, 0.2%, and 0.2%, respectively. This study successfully integrated sterile culture techniques, regeneration protocols, and CRISPR/Cas9-based genome editing to generate transgenic Cannabis lines with modified cannabinoid biosynthesis. These results provide a technical foundation for the development of stable, low-THC Cannabis cultivars through precise genetic modification.